Welcome to the GBM-X Data Platform
The site is designed by the Department of Data Science of the Dana-Farber Cancer Institute to facilitate use of external data in the design and analysis of clinical trials in newly diagnosed glioblastoma.
We believe in removing barriers to therapeutic advances for glioblastoma. This collection of well-annotated, patient-level datasets can serve as a powerful resource that can be used by investigators around the world to accelerate drug development for glioblastoma.